Publication | Closed Access

Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment

Medicinal ChemistrySelective Alk InhibitorsPharmaceutical ChemistryMedicinePharmacologyPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentOncologyRadiation OncologyNovel Bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidinesDrug DiscoveryAnticancer Treatment